Abbreviated Biparametric Prostate MR Imaging: Is It Really an Alternative to Multiparametric MR Imaging?

Published Online:
Free first page


  • 1. Kuhl CK, Bruhn R, Krämer N, Nebelung S, Heidenreich A, Schrading S. Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen. Radiology 2017;285(2):493–505. LinkGoogle Scholar
  • 2. Rais-Bahrami S, Siddiqui MM, Vourganti S, et al. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)–based detection of prostate cancer in men without prior biopsies. BJU Int 2015;115(3):381–388. Crossref, MedlineGoogle Scholar
  • 3. Scialpi M, Martorana E, D’Andrea A. Standardizing biparametric MRI to simplify and improve Prostate Imaging Reporting and Data System, version 2, in prostate cancer management. AJR Am J Roentgenol 2016;207(4):W74–W75. CrossrefGoogle Scholar
  • 4. Scialpi M, Prosperi E, D’Andrea A, et al. Biparametric versus multiparametric MRI with non-endorectal coil at 3T in the detection and localization of prostate cancer. Anticancer Res 2017;37(3):1263–1271. [Published correction appears in Anticancer Res 2017;37(7):3981.] Crossref, MedlineGoogle Scholar
  • 5. De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol 2017;72(1):23–32. Crossref, MedlineGoogle Scholar
  • 6. Fascelli M, Rais-Bahrami S, Sankineni S, et al. Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population. Urology 2016;88:125–134. Crossref, MedlineGoogle Scholar
  • 7. Prostate Imaging Reporting and Data System (PI-RADS). Reston, Va: American College of Radiology. Accessed March 5, 2015. Google Scholar
  • 8. Liddell H, Jyoti R, Haxhimolla HZ. mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer: a retrospective review of 92 biopsied PIRADS 3 lesions. Curr Urol 2015;8(2):96–100. Crossref, MedlineGoogle Scholar

Article History

Published online: Dec 20 2017
Published in print: Jan 2018